4
Changes in Ownership
Bolt Biotherapeutics, Inc. Filed Acc 0001193125-25-321148
Options or other derivatives
- Chief Operating Officer acquired 76,027 shares (grant or award)
- Chief Operating Officer returned 76,027 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Yonehiro Grant · Chief Operating Officer
Table II: Derivative
24 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-12 | Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) | +3,214 | 3,214 | D |
| 2025-12-12 | Returned to the company : show line 2 in the form Employee Stock Option (Right to Buy) | −3,214 | 0 | D |
| 2025-12-12 | Grant or award : show line 3 in the form Employee Stock Option (Right to Buy) | +660 | 660 | D |
| 2025-12-12 | Returned to the company : show line 4 in the form Employee Stock Option (Right to Buy) | −660 | 0 | D |
| 2025-12-12 | Grant or award : show line 5 in the form Employee Stock Option (Right to Buy) | +822 | 822 | D |
| 2025-12-12 | Returned to the company : show line 6 in the form Employee Stock Option (Right to Buy) | −822 | 0 | D |
| 2025-12-12 | Grant or award : show line 7 in the form Employee Stock Option (Right to Buy) | +1,653 | 1,653 | D |
| 2025-12-12 | Returned to the company : show line 8 in the form Employee Stock Option (Right to Buy) | −1,653 | 0 | D |
Loading xslF345X05/ownership.xml…